Consider other antidiabetic therapies in patients with history of pancreatitis (5.2). Hypoglycemia: When TRULICITY is used with an insulin.
Hypoglycemia: When Trulicity is used with an insulin secretagogue (e.g, a sulfonylurea) or insulin, consider lowering the dose of the sulfonylurea or
When initiating TRULICITY, consider reducing the dosage of concomitantly administered insulin secretagogues. (e.g, sulfonylureas) or insulin to reduce the risk
When initiating TRULICITY, consider reducing the dose of concomitantly administered insulin secretagogues (such as sulfonylureas) or insulin to reduce the
When initiating TRULICITY, consider reducing the dosage of concomitantly administered insulin secretagogues. (e.g, sulfonylureas) or insulin to reduce the risk
When initiating TRULICITY, consider reducing the dosage of concomitantly administered insulin secretagogues. (e.g, sulfonylureas) or insulin to reduce the risk
Consider automated insulin delivery (like an insulin pump) if appropriate Trulicity (dulaglutide). Possible side effects include nausea
Consider automated insulin delivery (like an insulin pump) if appropriate Trulicity (dulaglutide). Possible side effects include nausea
When initiating Trulicity, consider reducing the dose of concomitantly administered insulins and insulin secretagogues (such as sulfonylureas)
(Now where is the insulin? ;^> ;^> ;^> )